Literature DB >> 25716889

Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013.

Maria Gustafsson1, Per-Olof Sandman, Stig Karlsson, Ulf Isaksson, Jörn Schneede, Maria Sjölander, Hugo Lövheim.   

Abstract

PURPOSE: The aims of this study were to investigate trends in the prevalence of potentially inappropriate drug use among old people living in geriatric care units in the county of Västerbotten between 2007 and 2013 using six national quality indicators and to assess the impact of medication reviews on those quality indicators.
METHODS: Data were collected concerning potentially inappropriate drug use, function in the activities of daily living (ADL) and cognitive function, using the Multi-Dimensional Dementia Assessment Scale (MDDAS). A comparison was made between the years 2007 and 2013, comprising 2772 and 1902 people, respectively, living in geriatric care in the county of Västerbotten, Sweden. We conducted a parallel investigation of a separate corresponding population in Västerbotten County from 2012, where potentially inappropriate drug use was measured before and after 895 medication reviews which involved a clinical pharmacist.
RESULTS: After controlling for age, sex, ADL and cognitive impairment, there was a significant improvement in five out of six quality indicators between 2007 and 2013. While 44% of the people were exposed to one or more potentially inappropriate medications in 2007, this number had declined to 26% by 2013. In the separate population from 2012, the frequency of potentially inappropriate drug use was significantly reduced amongst the people who had a medication review performed.
CONCLUSION: The extent of potentially inappropriate drug use declined between 2007 and 2013 according to the quality indicators used. Medication reviews involving clinical pharmacists might be an important factor in reducing potentially inappropriate drug use and improving drug treatment among old people.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25716889     DOI: 10.1007/s00228-015-1825-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  37 in total

Review 1.  Psychotropic drugs and injuries among the elderly: a review.

Authors:  W A Ray
Journal:  J Clin Psychopharmacol       Date:  1992-12       Impact factor: 3.153

2.  Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients.

Authors:  Chia-Ming Chang; Pheng-Ying Yeh Liu; Yea-Huei Kao Yang; Yi-Ching Yang; Chun-Feng Wu; Feng-Hwa Lu
Journal:  Pharmacotherapy       Date:  2005-06       Impact factor: 4.705

3.  The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.

Authors:  Inga Klarin; Anders Wimo; Johan Fastbom
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Adverse drug reaction risk factors in older outpatients.

Authors:  Emily R Hajjar; Joseph T Hanlon; Margaret B Artz; Catherine I Lindblad; Carl F Pieper; Richard J Sloane; Christine M Ruby; Kenneth E Schmader
Journal:  Am J Geriatr Pharmacother       Date:  2003-12

Review 5.  Interventions to optimise prescribing for older people in care homes.

Authors:  David P Alldred; David K Raynor; Carmel Hughes; Nick Barber; Timothy F Chen; Pat Spoor
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  An innovative approach to integrated medicines management.

Authors:  Claire Scullin; Michael G Scott; Anita Hogg; James C McElnay
Journal:  J Eval Clin Pract       Date:  2007-10       Impact factor: 2.431

Review 7.  Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism.

Authors:  K I Melkersson; M-L Dahl; A-L Hulting
Journal:  Psychopharmacology (Berl)       Date:  2004-06-25       Impact factor: 4.530

8.  Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.

Authors:  Veronica Milos; Eva Rekman; Åsa Bondesson; Tommy Eriksson; Ulf Jakobsson; Tommy Westerlund; Patrik Midlöv
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

9.  Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients.

Authors:  R Adolfsson; C G Gottfries; L Nyström; B Winblad
Journal:  Acta Psychiatr Scand       Date:  1981-03       Impact factor: 6.392

10.  Antipsychotic drug use and mortality in older adults with dementia.

Authors:  Sudeep S Gill; Susan E Bronskill; Sharon-Lise T Normand; Geoffrey M Anderson; Kathy Sykora; Kelvin Lam; Chaim M Bell; Philip E Lee; Hadas D Fischer; Nathan Herrmann; Jerry H Gurwitz; Paula A Rochon
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

View more
  16 in total

1.  Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.

Authors:  Sofia Svahn; Hugo Lövheim; Ulf Isaksson; Per-Olof Sandman; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2020-01-08       Impact factor: 2.953

Review 2.  Principle of rational prescribing and deprescribing in older adults with multiple chronic conditions.

Authors:  Gregory M Ouellet; Jennifer A Ouellet; Mary E Tinetti
Journal:  Ther Adv Drug Saf       Date:  2018-08-09

3.  Prevalence of potentially inappropriate medications among old people with major neurocognitive disorder in 2012 and 2017.

Authors:  Iris Rangfast; Eva Sönnerstam; Maria Gustafsson
Journal:  BMC Geriatr       Date:  2022-06-30       Impact factor: 4.070

4.  Potentially Inappropriate Medications Pre- and Post-Diagnosis of Major Neurocognitive Disorders Among Older People in Sweden: A Register-Based, 6-Year Longitudinal Study.

Authors:  Eva Sönnerstam; Maria Gustafsson; Hugo Lövheim; Maria Sjölander
Journal:  Drugs Aging       Date:  2022-06-03       Impact factor: 4.271

5.  Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.

Authors:  Maria Gustafsson; Ulf Isaksson; Stig Karlsson; Per-Olof Sandman; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2016-04-13       Impact factor: 2.953

6.  An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list.

Authors:  Eva Sönnerstam; Maria Sjölander; Maria Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

7.  Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013.

Authors:  Eva-Stina Hemmingsson; Maria Gustafsson; Ulf Isaksson; Stig Karlsson; Yngve Gustafson; Per-Olof Sandman; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2017-12-20       Impact factor: 2.953

8.  Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting - Analysis of a Cluster Randomized Controlled Trial (WestGem-Study).

Authors:  Olaf Rose; Hugo Mennemann; Carina John; Marcus Lautenschläger; Damaris Mertens-Keller; Katharina Richling; Isabel Waltering; Stefanie Hamacher; Moritz Felsch; Lena Herich; Kathrin Czarnecki; Corinna Schaffert; Ulrich Jaehde; Juliane Köberlein-Neu
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

9.  Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study.

Authors:  Sabine Björk; Christina Juthberg; Marie Lindkvist; Anders Wimo; Per-Olof Sandman; Bengt Winblad; David Edvardsson
Journal:  BMC Geriatr       Date:  2016-08-22       Impact factor: 3.921

10.  Effects of Pharmacists' Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia-A Secondary Analysis of a Randomized Controlled Trial.

Authors:  Maria Gustafsson; Maria Sjölander; Bettina Pfister; Jörn Schneede; Hugo Lövheim
Journal:  Pharmacy (Basel)       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.